- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Sorafenib, as a multi kinase inhibitor, has clear contraindications, dietary restrictions, and special condition requirements for its use. The ...
The standard usage of Sorafenib is twice daily oral administration, taken on an empty stomach. For special populations, the dosage should be ad...
Dasatinib is a tyrosine kinase inhibitor primarily used for the treatment of hematological malignancies with specific gene mutations. Its use r...
Ocaliva, as a therapeutic drug for primary biliary cholangitis, mainly has side effects on the liver and gallbladder system, metabolic abnormal...
Ocaliva is a medication used for specific liver diseases, and its indications and medication precautions must strictly follow clinical guidelin...
The contraindications of Ocaliva involve specific disease states, physiological stages, and dietary restrictions, and must be strictly followed...
Ocaliva is a farnesol X receptor agonist primarily used for the treatment of primary biliary cholangitis (PBC). The following provides detailed...
The contraindications and use of Brigatinib in special populations must strictly follow clinical guidelines, involving risk management for spec...
As a targeted therapy drug, the use of Brigatinib has clear contraindications, dietary restrictions, and special condition constraints. The f...
Brigatinib is a targeted therapy for ALK positive non-small cell lung cancer, with clear indications and multiple precautions to be taken when ...
